Roche Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ROCHE, and what generic and branded alternatives to ROCHE drugs are available?
ROCHE has sixty-one approved drugs.
Summary for Roche
US Patents: | 0 |
Tradenames: | 49 |
Ingredients: | 45 |
NDAs: | 61 |
Patent Litigation for Roche: | See patent lawsuits for Roche |
Drugs and US Patents for Roche
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | TRIMPEX | trimethoprim | TABLET;ORAL | 017952-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Roche | KYTRIL | granisetron hydrochloride | INJECTABLE;INJECTION | 020239-003 | Sep 17, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Roche | LARODOPA | levodopa | TABLET;ORAL | 016912-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Roche | DEMADEX | torsemide | INJECTABLE;INJECTION | 020137-001 | Aug 23, 1993 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Roche
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | HIVID | zalcitabine | TABLET;ORAL | 020199-002 | Jun 19, 1992 | 4,879,277 | ⤷ Try a Trial |
Roche | TAMIFLU | oseltamivir phosphate | FOR SUSPENSION;ORAL | 021246-002 | Mar 21, 2011 | 5,866,601*PED | ⤷ Try a Trial |
Roche | DEMADEX | torsemide | INJECTABLE;INJECTION | 020137-002 | Aug 23, 1993 | 4,861,786 | ⤷ Try a Trial |
Roche Palo | CELLCEPT | mycophenolate mofetil hydrochloride | INJECTABLE;INJECTION | 050758-001 | Aug 12, 1998 | 5,543,408 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ROCHE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 1 mg/mL, 1 mL vials | ➤ Subscribe | 2004-06-01 |
➤ Subscribe | Injection | 1 mg/mL, 3 mL Vial | ➤ Subscribe | 2007-08-31 |
➤ Subscribe | For Oral Suspension | 200 mg/mL | ➤ Subscribe | 2011-03-25 |
➤ Subscribe | Capsules | 30 mg and 45 mg | ➤ Subscribe | 2011-08-02 |
➤ Subscribe | Injection | 0.1 mg/mL, 1 mL single dose vial | ➤ Subscribe | 2007-03-08 |
➤ Subscribe | Injection | 1 mg/mL, 4 mL multi-dose vials | ➤ Subscribe | 2004-07-19 |
➤ Subscribe | Tablets | 2.5 mg and 150 mg | ➤ Subscribe | 2007-05-16 |
➤ Subscribe | Capsule | 75 mg | ➤ Subscribe | 2010-11-15 |
➤ Subscribe | Oral Suspension | 6 mg/mL | ➤ Subscribe | 2015-06-18 |
Similar Applicant Names
Here is a list of applicants with similar names.